Compare AHCO & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHCO | SLRC |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.5M | 691.2M |
| IPO Year | 2017 | 2007 |
| Metric | AHCO | SLRC |
|---|---|---|
| Price | $5.63 | $12.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $13.50 | ★ $15.14 |
| AVG Volume (30 Days) | ★ 4.0M | 414.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 10.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | ★ $3,244,857,000.00 | N/A |
| Revenue This Year | $9.00 | $1.09 |
| Revenue Next Year | $6.93 | N/A |
| P/E Ratio | ★ N/A | $26.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $12.13 |
| 52 Week High | $13.43 | $16.75 |
| Indicator | AHCO | SLRC |
|---|---|---|
| Relative Strength Index (RSI) | 25.61 | 44.82 |
| Support Level | $5.21 | $12.47 |
| Resistance Level | $10.71 | $13.33 |
| Average True Range (ATR) | 0.39 | 0.25 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 18.96 | 22.76 |
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.